NeuroSync
PrivateLast Round
Seed
Mar 11, 2019
Total Funding Raised
$4.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroSync is a neurotechnology company that provides a cloud-based analytics platform for assessing abnormal eye movements to aid in the diagnosis and treatment of various neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, AR/VR Hardware, Sports & Fitness
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSync Comps
Public and private peers based on sector, stage, and business model.
NeuroSync Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 11, 2019 | ||||
| Series A Extension | Jan 3, 2018 | ||||
| Seed | Sep 7, 2017 | ||||
| Grant | Jun 13, 2017 | ||||
| Accelerator | Apr 4, 2017 |
NeuroSync Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Quadrant Management | Series A Extension |
| MassChallenge | Grant, Accelerator |
| StartUp Health | Seed |
| Quartus Capital Partners | Growth Equity |
| Oceanic Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 11, 2025
EyeSync TBI technology has received FDA clearance.
- Oct 11, 2025
Platform trusted by over 5,000 providers.
NeuroSync Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroSync's valuation, stock price, and market status.
